These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 39069431

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A Review of Omadacycline for Potential Utility in the Military Health System for the Treatment of Wound Infections.
    Zurawski DV, Serio AW, Black C, Pybus B, Akers KS, Deck DH, Johnson S, Chattagul S, Noble SM, Raynor M, Lanteri CA.
    Mil Med; 2024 May 18; 189(5-6):e1353-e1361. PubMed ID: 37963013
    [Abstract] [Full Text] [Related]

  • 23. Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients.
    Li L, Wu H, Chen Y, Yuan H, Wu J, Wu X, Zhang Y, Cao G, Guo B, Wu J, Zhao M, Zhang J.
    Clin Ther; 2020 May 18; 42(5):818-829. PubMed ID: 32389326
    [Abstract] [Full Text] [Related]

  • 24. Population Pharmacokinetics of Doripenem in Pediatric Patients and Monte-Carlo Pharmacokinetic-Pharmacodynamic Simulations for Dosing Regimen Assessment.
    Matsuo Y, Ishibashi T, Matsumoto S, Katsube T, Wajima T.
    J Pharm Sci; 2019 Sep 18; 108(9):3099-3105. PubMed ID: 30974120
    [Abstract] [Full Text] [Related]

  • 25. Safety and Pharmacokinetics of the Aminomethylcycline Antibiotic Omadacycline Administered to Healthy Subjects in Oral Multiple-Dose Regimens.
    Bundrant LA, Tzanis E, Garrity-Ryan L, Bai S, Chitra S, Manley A, Villano S.
    Antimicrob Agents Chemother; 2018 Feb 18; 62(2):. PubMed ID: 29180524
    [Abstract] [Full Text] [Related]

  • 26. In Vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model.
    Lepak AJ, Zhao M, Marchillo K, VanHecker J, Andes DR.
    Antimicrob Agents Chemother; 2017 May 18; 61(5):. PubMed ID: 28193651
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 Data.
    Lakota EA, Van Wart SA, Trang M, Tzanis E, Bhavnani SM, Safir MC, Friedrich L, Steenbergen JN, Ambrose PG, Rubino CM.
    Antimicrob Agents Chemother; 2020 Jun 23; 64(7):. PubMed ID: 32340986
    [Abstract] [Full Text] [Related]

  • 29. The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints.
    Stass H, Dalhoff A.
    Infection; 2005 Dec 23; 33 Suppl 2():29-35. PubMed ID: 16518709
    [Abstract] [Full Text] [Related]

  • 30. Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial.
    O'Riordan W, Cardenas C, Shin E, Sirbu A, Garrity-Ryan L, Das AF, Eckburg PB, Manley A, Steenbergen JN, Tzanis E, McGovern PC, Loh E, OASIS-2 Investigators.
    Lancet Infect Dis; 2019 Oct 23; 19(10):1080-1090. PubMed ID: 31474458
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Population Pharmacokinetic Modeling Using Polymyxin B Free Plasma Concentrations From Published Reports and Evaluation of Dosage Regimens Based on Monte Carlo Simulation in Critically Ill Patients.
    Zheng Y, Xu B, Chen S, Liu M, Huang H, Wang J, Wu X.
    J Clin Pharmacol; 2023 Sep 23; 63(9):1036-1044. PubMed ID: 37125471
    [Abstract] [Full Text] [Related]

  • 35. Population Pharmacokinetics and Pharmacodynamics Modeling of Oral Levofloxacin.
    Jaruratanasirikul S, Jaspattananon A, Wongpoowarak W, Nawakitrangsan M, Thengyai S, Samaeng M.
    J Med Assoc Thai; 2018 Aug 23; 99(8):886-92. PubMed ID: 29947489
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulation.
    Tanigawara Y, Nozawa K, Tsuda H.
    Eur J Clin Pharmacol; 2012 Jan 23; 68(1):39-53. PubMed ID: 21796376
    [Abstract] [Full Text] [Related]

  • 40. Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects.
    Sun H, Ting L, Machineni S, Praestgaard J, Kuemmell A, Stein DS, Sunkara G, Kovacs SJ, Villano S, Tanaka SK.
    Antimicrob Agents Chemother; 2016 Dec 23; 60(12):7431-7435. PubMed ID: 27736760
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.